Cochlear gets US clearance to market Osia system
Bionic ear manufacturer Cochlear (ASX: COH) has received FDA clearance to market its Osia 2 bone implant in the US for those older than 12 years of age with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness. Unlike its traditional implant which stimulates the cochlea with electrical signals, the Osia is an implant…